Skip to main content
. 2020 Mar 11;12(5):4337–4347. doi: 10.18632/aging.102883

Table 3. Blood parameters and vascularisation; prostate size < 70 mL.

Group A < 70 mL (placebo) Group B < 70 mL (dutasteride) p value
Hemoglobin before HoLEP, (g/dl) ± SD 14.00 ± 2.02 14.24 ± 2.15 0.88
Hemoglobin after HoLEP, (g/dl) ± SD 12.88 ± 1.94 12.99 ± 2.01 0.76
ΔHb ±SD 1.12 ± 0.12 1.15 ± 0.13
Hematocrit before HoLEP, % ± SD 43.25 ± 3.90 42.18 ± 4.07 0.44
Hematocrit after HoLEP, % ± SD 41.98 ± 4.03 41.17 ± 4.17 0.21
ΔHt ±SD 1.17 ± 0.21 1.33 ± 0.20
MVD 23.35 ± 1.96 19.04 ± 0.96 < .05
VEGF index 4.06 ± 0.76 2.55 ± 0.55 < .05

HoLEP: Holmium Laser Enucleation of the Prostate; MVD: microvascular density; VEGF index: vascular endothelial growth factor index; SD: standard deviation.